Stocks
Bank OZK Bets on Biotech with New Stake in Amgen
Bank OZK acquired a new stake in Amgen Inc. shares during the second quarter, purchasing 11,793 shares worth approximately $4,270,000.
This investment makes up about 1.3% of Bank OZK's portfolio and is its 22nd biggest position among all holdings.
The firm joins other large investors who have also made changes to their positions in Amgen, with Brighton Jones LLC increasing its stake by 23.5%, Sivia Capital Partners LLC boosting its holding by 10.6%, and Schnieders Capital Management LLC expanding its investment by 29.3%.